MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/oncolo/oyag324

Медицинская библиотека · The oncologist · 2026

Novel genomic score predicts survival with immune checkpoint inhibition in neuroendocrine neoplasms.

Brar Tanvi, Olowookere Charles, Le Dat, Xu Menglin, Konda Bhavana, Sukrithan Vineeth

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Immune checkpoint inhibition (ICI) has activity in Grade 3 (G3) neuroendocrine neoplasms (NENs), but predictive biomarkers of long-term overall survival (OS) are currently lacking.

METHODS

We derived a genomic scoring system using a retrospective cohort of 54 NEN patients treated with nivolumab and/or ipilimumab, alongside a chemotherapy-only control (n = 15) and pan-cancer validation cohort (n = 1661). An overall genomic score (GS-O) combining positive (GS-P) and negative response genes (GS-N) was calculated.

RESULTS

In the ICI cohort, patients with GS-O ≥ 2 had significantly better outcomes: median OS was not reached, compared to 3.9 months for low scores (HR = 0.007, P < .001). After multivariate adjustment, GS-P was independently associated with improved OS while GS-N showed a trend towards worsened OS. Importantly, GS-O ≥ 2 did not predict survival in the chemotherapy-alone cohort but was validated as independently predictive in the pan-cancer validation dataset (HR = 0.92, P < .001).

CONCLUSION

This study establishes a novel genomic score to predict OS in NENs treated with ICI with important pan-cancer implications.

Для цитирования: Brar Tanvi, Olowookere Charles, Le Dat, Xu Menglin, Konda Bhavana, Sukrithan Vineeth. Novel genomic score predicts survival with immune checkpoint inhibition in neuroendocrine neoplasms.. The oncologist. 2026. DOI: 10.1093/oncolo/oyag324.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.